openPR Logo
Press release

Hemoglobinopathy Market Forecast Growing at 8.3% CAGR to Reach $1.7 Billion by 2034

04-24-2024 04:48 PM CET | Health & Medicine

Press release from: Fact.MR

Hemoglobinopathy Market Forecast Growing at 8.3% CAGR to Reach

In 2024, the global hemoglobinopathy market (ヘモグロビン症市場) is estimated to be worth US$788.1 million, with a projected compound annual growth rate (CAGR) of 8.3% through 2034. By 2034, the market size is expected to exceed US$1,745.7 million. The rise of genetic testing has led to a significant shift in the hemoglobinopathy market towards personalized medication. Companies are leveraging this trend to develop tailored treatment plans based on each patient's DNA profile. This strategic shift not only meets the growing demand for precise medical solutions but also enhances therapeutic effectiveness. Embracing personalized medicine enables stakeholders to better position themselves in the market, meet evolving patient needs, and establish themselves as leaders in innovative treatment approaches.

Get Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9406

Telemedicine and remote monitoring technologies are increasingly being incorporated into hemoglobinopathy market strategies. By embracing and using these technologies, businesses are putting themselves in a position to maximize operational effectiveness, improve care management, and increase patient accessibility. This deliberate use of telehealth solutions aligns with more general industry developments and addresses the growing need for accessible, patient-focused healthcare services. Businesses strategically using telemedicine can obtain a competitive advantage in the rapidly changing healthcare market.

In the hemoglobinopathy industry, integrating cutting-edge technologies like artificial intelligence (AI) and machine learning is competitively essential. Businesses that use these technologies strategically stand to gain advantages in data analysis, improved diagnosis accuracy, and expedited treatment planning. This deliberate integration responds to the need for efficiency and innovation in technology while aligning with more general healthcare trends. Businesses that strategically adopt technology integration stand to benefit from a competitive edge that will propel them to operational excellence and solidify their leadership in the ever-changing field of hemoglobinopathy treatments.

Key Takeaways from the Hemoglobinopathy Market (혈색소병증 시장) Report

The global hemoglobinopathy market size stood at US$ 2,634.9 million in 2019.
The North America hemoglobinopathy market holds a 20.5% of the market share in 2024.
The East Asia hemoglobinopathy market holds 6.9% of the market share in 2024.
The routine red blood cell (RBC) count test type segment is expected to occupy 28.5% of the market share in 2024.
The diagnostic laboratories segment is estimated to capture 51.7% of the market share in 2024.
The market size in the United States is projected to rise at a 7.6% CAGR through 2034.
The market size in China is anticipated to develop at an 8.7% CAGR through 2034.

Country-wise Insights

Over the course of the projection period, a large expansion of the hemoglobinopathy market in North America is expected. The market for hemoglobinopathy in the US is anticipated to develop at the fastest rate, 7.6% CAGR, until 2034. With an 8.7% CAGR through 2034, China is predicted to lead the East Asia hemoglobinopathy market.

Key Companies Profiled in This Report

Novartis AG
Bluebird Bio, Inc.
Global Blood Therapeutics, Inc.
CRISPR Therapeutics
Editas Medicine
Sangamo Therapeutics
Acceleron Pharma, Inc.
Emmaus Life Sciences, Inc.
Gamida Cell Ltd.
Vertex Pharmaceuticals Incorporated
PTC Therapeutics, Inc.
Kiadis Pharma
Incyte Corporation
Celgene Corporation (acquired by Bristol Myers Squibb)
Lonza Group AG
Orchard Therapeutics plc
Apellis Pharmaceuticals
Regeneron Pharmaceuticals, Inc.
Bluebird Bio, Inc.
Sanofi S.A.

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=9406

Competitive Landscape

The market for hemoglobinopathy is extremely competitive, with prominent companies like Novartis AG and Bluebird Bio at the forefront. These businesses highly value strategic alliances, active R&D, and access to international markets. Observing regulations is essential for receiving permissions on schedule. Companies stand out for their technological leadership, particularly in gene editing. The market is dynamic due to fierce rivalry and an emphasis on innovation.

Recent Developments

In October 2023, Sanguina, Inc. (Sanguina), a leading biotech company, announced that AnemoCheck Home, the only FDA-cleared home hemoglobin test kit available in the United States, had acquired FDA clearance.

In June 2023, Mylab Discovery Solutions announced the PathoCatch Sickle Cell quick test for Sickle Cell Anemia as a strip-based, rapid point-of-care diagnostic. This CDSCO-approved test aims to transform how healthcare practitioners diagnose and manage SCA by giving rapid and reliable results at the patient's location.

Hemoglobinopathy Market (Markt für Hämoglobinopathie) Segmentation

By Test Type :

Routine Red Blood Cell (RBC) Count

Genetic Testing

Hemoglobin by High Performance Liquid Chromatography

Isoelectric

Hemoglobin Solubility Test

By Indication :

Sickle Cell Disease

Beta Thalassemia

Alpha Thalassemia

By End User :

Hospitals

Diagnostic Laboratories

Clinics

By Region :

North America

Europe

Latin America

East Asia

South Asia & Oceania

Middle East & Africa

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hemoglobinopathy Market Forecast Growing at 8.3% CAGR to Reach $1.7 Billion by 2034 here

News-ID: 3475319 • Views:

More Releases from Fact.MR

Automated Blood Tube Labeler & Specimen Transport Box Market Growth Research | Fact.MR
05-14-2024 | Health & Medicine
Fact.MR
Automated Blood Tube Labeler & Specimen Transport Box Market Growth Research | F …
According to projections, the global Automated Blood Tube Labeler & Specimen Transport Box Market will reach US$ 282.5 million in 2022 and grow at a compound annual growth rate (CAGR) of 7.5% until 2026. The healthcare industry uses automatic blood tube labelers and specimen transport boxes to reduce human mistake and ensure safe specimen delivery from hospitals to laboratories. Automatic blood tube labelers are used extensively worldwide because they offer
Embolotherapy Market Is Anticipated To Expand At A Cagr Of 8.4% To Reach Us$ 7,942.8 Million By 2032
05-13-2024 | Health & Medicine
Fact.MR
Embolotherapy Market Is Anticipated To Expand At A Cagr Of 8.4% To Reach Us$ 7,9 …
From its present valuation of US$ 3,545.56 million to US$ 7,942.8 million by the end of 2032, the global Embolotherapy Market is expected to grow at a compound annual growth rate (CAGR) of 8.4%. Because of the rising incidence of cancer and the major players' increased emphasis on technology developments, the market is anticipated to expand. Embolotherapy market growth is anticipated to be fueled by rising investments in healthcare infrastructure
Organic Mattress Market Forecasted to Achieve US$ 13.87 Billion by 2032
Organic Mattress Market Forecasted to Achieve US$ 13.87 Billion by 2032
The global Organic Mattress Market (유기농 매트리스 시장) was valued at US$ 6.31 Billion in 2022. Predicted to grow at a significant CAGR of 8.2% from 2022 to 2032, it is expected to reach US$ 13.87 Billion by 2033. The organic mattress market has witnessed a surge in popularity in recent years as consumers become increasingly conscious of the materials they bring into their homes. Unlike conventional mattresses made with
Wireless Network Test Equipment Market to Reach $9.1 Billion by 2032 with 7.6% CAGR
Wireless Network Test Equipment Market to Reach $9.1 Billion by 2032 with 7.6% C …
The global Wireless Network Test Equipment Market (무선 네트워크 테스트 장비 시장) was valued at US$ 4.36 Billion in 2022. Predicted to grow at a significant CAGR of 7.6% from 2022 to 2032, it is expected to reach US$ 9.1 Billion by 2032. The wireless network test equipment market plays a crucial role in ensuring the reliability, performance, and efficiency of wireless communication networks. These testing tools are essential for

All 5 Releases


More Releases for CAGR

Cat Litter Box Market | CAGR of 9.1% | Revenue & CAGR of 9.1%
Cat Litter Box Market Report provides precise data about the market size, commercialization aspects and revenue forecast of the industry. The global Cat Litter Box market offers a historical factsheet relevant to the strategic mergers, acquirements, joint venture activities, and partnerships spread in the Cat Litter Box market. The most advanced data has been presented in the study on the revenue numbers, product details, and sales of the major firms.
Predictive Analytics Market Growing at Strong CAGR of CAGR of 25.31% 2019
Predictive analytics helps to extract information from the existing data. It helps in understanding the pattern and predict the trend or future for the organization. It uses what-if scenarios to predict possible risks involved in the future. Predictive analytics also helps in the optimization of the marketing campaigns and understanding of the customer behaviour for increasing the end-user response and to reduce the churn. Predictive analytics is segmented into: Risk management:
Global Absorption Chillers Market Reflecting a CAGR of 7.6% CAGR through 2025
The demand for thermally-driven chillers in multiple industrial verticals is poised to grow in the immediate future. Considering the rising demand for electrical chillers in commercial, residential as well as industrial settings, the adoption of absorption chillers will gain traction at considerable rate. By consuming lesser energy than conventional electrical chillers, absorption chillers will also garner surplus demand for not using ozone-depleting chlorofluorocarbons (CFC) for chilling purposes. Persistence Market Research’s
Aircraft Sensors Market Growing at a CAGR of 6.4% CAGR By 2022
The global aircraft sensors market is forecasted to receive a strong push in its growth momentum on the back of advancements in technologies, massive investments forwarded by private equity groups, and the elevation in the demand for aircraft. Adherence to the requirements and regulations of authorities such as local aircraft regulatory bodies and the Federal Aviation Administration (FAA) could pamper the growth of the market. Nonetheless, there could be more
China Baby Diapers Market Reflecting a CAGR of 19.1% CAGR 2012-2017
The increasing birth rate in China has proven to be a boon for the country’s baby diaper’s market. To provide a comprehensive analysis of the growth trajectory exhibited by the China baby diapers market and study the impact of the dynamic regulatory policies on the market, Transparency Market Research (TMR) has published a report, titled “Baby Diapers Market - China Industry Analysis, Market Size, Share, Growth, Trends And Forecast, 2012
Ecg Device Market Register a CAGR Growth of 4.1% CAGR by 2024
This region holds highest market share over the forecast period (2016-2024) and is expected to exhibit slow growth rate. The Asia Pacific is expected to be the fastest-growing region for ECG devices owing to its increasing incidence rate of cardiovascular diseases and high population. ECG devices are experiencing a paradigm technological shift from resting ECG systems to portable Holter monitoring systems, owing to their advantages of patient mobility, low prices and